Episodes
-
On this episode of the SCR Podcast we are hosting Jeroen Tas who has a rermarkable career both as an entrepreneur scaling his company to $1+ billion in revenues, which got acquired by HP and being a senior executive as the former Chief Innovation Officer of Royal Philips.
Together with Jeroen we are starting the epsiode with discussing the critical skill of identifying windows of opportunities as an entrepreneur. Jeroen also shares his opinion on why he believes that early stage startups should be careful when choosing "random" revenue rather than focusing on developing a robust and visionary product.
-
On this episode of the SCR Podcast we are hosting Alex Louisy who is the Co-Founder and CEO of Upflow (YCW20).
Together with Alex we start-off by discussing all things that a second-time founder does different. Alex is sharing his experience of starting a company in France, getting into YC and pivoting the business by tackling the US market. Beyond that we also touch upon Stripe's concept of macro optimism/micro pessimism and exchange on the factual meaning of VC-Founder partnerships.
-
Episodes manquant?
-
On this epsiode we are honored to host Phil Libin who is a serial entrepreneur. Among the companies he co-founded are Evernote, All Turtles and mmhmm. He is an expert in building great products with hundreds of millions of users.
Together we are getting Phil's opinion on building winning products that solve real problems and what it means to being a great product person. Phil also shares his opinion on why being opinionated in the early stages of building a product is far more important than talking to customers.
Tune in and subscribe to the SPEED CHANGE REPEAT Podcast for a weekly episode.
-
On this epsiode we are hosting Matt Brown who is a Partner at the early stage VC firm Matrix, based in San-Francisco and Boston.
Matt previously founded Bonsai and Work4 and led merchant product at Afterpay.
Together we are diving into the art of balancing early stage product building and the ever increasing importance of distribution and challenges around platform dependencies. We are also covering a new defining category of SaaS products, which Matt labels as VERPs: Vertical ERPS.
Tune in and subscribe to the SPEED CHANGE REPEAT Podcast for a weekly epsiode!
-
On this epsiode we are hosting the Lucy Jung who is the Co-Founder and CEO of Charco Neurotech, a company that developed a non-invasive wearable device for Parkinson's disease.
Together with Lucy we dive into the ins-and-outs of product design and development for hardware and medical products. Lucy gives an insight into her fundraising experiences and what it means to develop a global distribution system as a start-up.
-
For the first epsiode of the year we are starting with a little 2022 reflection on the podcast and the take aways for the upcoming year of hosting the show.
The SPEED CHANGE REPEAT Podcast is going to be a place where some of the worlds most incredible founders and operators will share their learnings and experiences from building tech companies.
We are starting-off the year strong with upcoming conversations, hosting Phil Libin (Co-Founder of Evernote) and Jeffrey Kaditz (Co-Founder of Affirm)
-
Dr. BJ Fogg is a behavior scientist and Adjunct Professor at Stanford University where he founded the Behavior Design Lab.
BJ is an expert on behavior change for health habits and author of the book "Tiny Habits", which is a New York Times Bestseller.
Among many of the interesting topics in this episode we are diving into the details of changing behavior towards improving human health and discuss the challenges of the healthtech start-up ecosystem targeting behavior change as a feature.
We are also touching BJ's new area of interest, which is tackling the science behind bad habits and approaches of tackling them.
-
On this episode of the SPEED CHANGE REPEAT Podcast we are talking with Florian Brand who is CEO and Co-Founder at ATAI Life Sciences.
The company is aiming to develop differentiated treatments for patients suffering from mental health orders.
Having collected over $500m in capital with noteable backing from investors such as Cathie Wood at ARK Invest, ATAI is at the forefront when it comes to the psychedelics market.
Together with Florian we are covering the early founding of the company and dive deep into the company's funding model for compound development as well as the role of digital therapeutics in ATAI's treatment strategy.
-
On this epsiode we are hosting Tero-Pekka Alastalo.
Tero and his team founded BluePrint Genetics a Stanford University spin off that has been focusing on developing innovative technologies for rare disease genetic diagnostics. The company was acquired by Quest Diagnostics in 2020.
Together we are talking about the early stages of building Blueprint Genetics and the aspects of expanding companies in the US market.
We also cover venture opportunities for heart health and talk about CardioSignal, which is developing a disruptive mobile application-based technology to improve the detection of heart disease.
-
On this episode we are hosting Jason Moore who is the CEO of Spren a company focused on providing insights into human biology through its digital biomarker platform.
Jason and his team have been operating a profitable business for years before deciding to take a turn and take on venture capital to execute on a bigger vision. The company now provides biometric data through its SDK to other players in the health and wellness space.
We are talking about their bootstrapping journey and the different product development stages before they took on external funding as well as the product roadmap for the company in the overall digital health vertical.
-
On this episode of the SPEED CHANGE REPEAT Podcast we are hosting Corbin Petro who is the CEO and Co-Founder of Eleanor Health.
The company has raised $82m to date and is building a hybrid care model for mental health and substance use disorder. Together with Corbin we tackled the founding story behind the company and the learnings she took from her past experience in healthcare.
Among many exciting topics we cover the go-to-market strategy of Eleanor and dive deeper into the reasons of why it is challenging to get a healthcare venture right.
-
On this episode of the SPEED CHANGE REPEAT Podcast we are hosting Matteo Franceschetti the CEO and Co-Founder of Eight Sleep.
The team at Eight Sleep managed to raise about $160m from leading funds such as Khosla Ventures, SoftBank or General Catalyst but also Angels such as Kevin Hart.
Eight Sleep is transforming the sleeping experience with their products by capturing incredible data on a person's health and providing the right sleeping temperature through their hydro-powered cooling technology.
Together with Matteo we are talking about his entrepreneurial journey and the journey of building Eight Sleep. We touch upon the challenges of building hardware products as well as some fundraising stories.
-
On this epsiode we are chatting with Andrew Herr who took his expertise from optimizing Nacy SEALs and pro-sports teams to build a scalable product through his venture Fount.
Together with Andrew we are talking about the founding story of Fount and talk about the product they are building with his team and how they strive to build digital product experiences.
We also dive into the data set they are building up taking a deep dive into the different health variables they are tracking and the reasoning behind the types of biomarkers and the frequency they collect.
-
Together with Mette Dhyrberg Co-Founder & CEO of health tech company Mymee.
The company has developed a digital approach to managing autoimmune diseases, which combines a mobile app, data analytics and certified health coaches to identify triggers for disease symptoms.
We are diving into the approach Mette has taken together with her Co-Founder in building within the health space.
-
On this episode of the SPEED CHANGE REPEAT Podcast we are hosting the CEO & Co-Founder of Nightingale Health, the Finnish company behind the ground-breaking blood testing technology.
Together with Teemu we are tackling the founding story of the company and what it means to move from being a biotech company to a digital health company. We also dive deeper into the reasoning behind different market entry strategies and why Nightingale went public in Finnland.
-
Stefan is the Co-Founder and CEO of FLOWBIO, a start-up focused on building the first real sweat sensor.
Together we are diving into Stefan's founder story and the vision for FLOWBIO and how they plan to position themselves within the wearable market.
Stefan is giving us an insight into the early days of forming the company and how his Co-Founder and CTO tackled the hardware challenge for developing a proper sweat sensor.
-
Joseph is a Professor of Dermatology at Harvard University. He is also the Editor-in-Chief of npj Digital Medicine one of the most relevant academic journals for publications at the intersection of innovation and digital health. Beyond that Joseph has been working and adivsing different healthtech ventures over the past years.
Together with Joseph we dove into the status-quo for the most relevant digital health applications and discussed opportunities and challenges.
-
Excited to host Rachel Soper Sanders who is teh Co-Founder and CEO of Rootine a health and wellness company focused on optimizing cellular nutrition through better data science and personalized health solutions to help people perform at their best everyday.
Rachel started Rootine shortly after finishing her MBA at Harvard and meeting her Co-Founder.
Together we are covering different topics around building ventures for personalized health and the opportunities and benefits related to optimizing a persons nutrient levels.
-
For this episode on the SCR Podcast we hosted David Mehlman founder of Ommyx.
Together with his team they are working on decoding personal health data across different tracking devices to determine what works best on an individual level.
David gives us an insight on his perspective for the connected health segment and the opportunities and challenges he sees. We are talking about different approaches and the go-to-market strategies for personalized health ventures.
Due to the recent turn in sentiment within the VC and start-up world we also touched upon the status-quo of the market and what it means for start-ups raising capital.
-
Phil Southerland is the CEO and Co-Founder of Supersapiens.
In 2019, Supersapiens approached Abbott about bringing their technology to the athletic community, and a partnership was soon established.
In September 2020, Abbott announced that its Libre Sense Glucose Sport Biosensor had achieved a CE Mark. It is the first CGM approved for non-diabetic use in the world.
By combining Abbott's proven track record in glucose sensing technology along with Supersapiens' app and personalized analytics, athletes are able to better understand the correlation between their glucose levels and their athletic performance.
- Montre plus
